Localized scleroderma is a skin condition where the skin thickens in specific areas. It's like a milder form of scleroderma, affecting only the skin, not the internal organs. The skin might look like a patch, a band, or a nodule. It's often called morphea.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Localized Scleroderma?
Localized scleroderma, usually called morphea, is an autoimmune condition in which the body lays down too much collagen in one or more areas of skin. The affected skin becomes thick, firm and often shiny. An active patch may look pink or purple, sometimes with a purplish ring at its edge, and later turns pale or ivory in the center. Over time it can leave darker or lighter skin, or a dip where tissue has thinned. The pattern matters. Plaque morphea, the most common form in adults, causes oval patches, often on the trunk, that are usually limited to the skin. Linear morphea, the most common form in children, forms a band along an arm, leg or the trunk, or on the forehead and scalp (a form called en coup de sabre, French for "sword cut"). Generalized morphea means patches in three or more body areas, and deep morphea mainly affects the fat and tissue beneath the skin rather than the skin surface. Linear and deep forms can reach the fat, muscle, joints and bone beneath the skin, which is where most of the lasting problems come from. Despite the shared name, localized scleroderma is a different disease from systemic sclerosis. It does not damage internal organs such as the lungs, heart or kidneys, and it does not turn into systemic sclerosis.
The cause of morphea is not fully understood. It is thought to involve an immune reaction that drives skin cells to overproduce collagen, in people who carry certain inherited immune-system gene types. It is not passed down directly from parent to child. Morphea is more common in women and girls. In children it usually starts between ages 2 and 14; in adults, onset is most often in middle age. People with morphea, especially the more extensive forms, are somewhat more likely to have another autoimmune condition, such as thyroid disease, or a family member with one. Some patches appear after local skin injury, such as surgery, radiation treatment, an injection or repeated rubbing from a waistband or bra strap. These are triggers in some people rather than causes, and most people cannot identify any trigger at all.
A dermatologist or rheumatologist can often recognize morphea by its appearance and feel. A skin biopsy, in which a small piece of skin and the fat beneath it is removed for examination under a microscope, can confirm the diagnosis when it is uncertain. The physical examination also looks for signs that point toward systemic sclerosis instead, such as thickened fingers, fingers that turn white or blue in the cold (Raynaud phenomenon) or abnormal tiny blood vessels at the nail folds. Morphea does not cause these. No blood test diagnoses morphea. Blood work may be used to check for inflammation, other autoimmune conditions and, when joints are painful, arthritis. An antinuclear antibody (ANA) test is positive in up to half of people with morphea, so a positive result does not mean a person has systemic sclerosis or lupus. The next step is judging how active and how deep the disease is, because that drives treatment. A clinician looks for redness, a purple edge, new patches or growing ones, and examines the joints for reduced movement. An MRI scan may be used when a patch crosses a joint or seems to reach muscle. For lesions on the face or scalp, specialists recommend an MRI of the head, an eye examination to screen for inflammation inside the eye (uveitis), which often causes no symptoms, and a dental and jaw assessment. Children with suspected morphea are best assessed at a pediatric rheumatology center.
Treatment aims to stop active inflammation before it causes permanent hardening, tissue loss or joint problems. It cannot fully undo damage that has already happened, so the choice depends on the form of morphea, where it is and whether it is still active. For limited plaques, treatment is usually applied to the skin. Strong corticosteroid creams or ointments are the mainstay; tacrolimus ointment (a non-steroid ointment that calms the immune response in the skin), calcipotriene (calcipotriol, a vitamin D-based cream) and imiquimod cream are alternatives with smaller amounts of evidence. Phototherapy, a series of controlled ultraviolet light treatments in a clinic, can soften plaques. It takes many clinic sessions, often continued as maintenance, which adds up to substantial ultraviolet exposure over time. PUVA, which pairs ultraviolet A light with a light-sensitizing medicine called psoralen, is generally avoided in children because of long-term skin risks. For linear, deep, generalized or rapidly spreading morphea, and for most children with linear disease, specialists recommend methotrexate, an immune-suppressing medicine taken once a week by mouth or injection. A course of corticosteroids by mouth or by intravenous infusion is often added for the first few months to calm inflammation while methotrexate takes effect. Treatment usually continues for at least a year after the disease settles, since stopping early makes relapse more likely. Methotrexate needs regular blood tests, and it must not be used during pregnancy, so people who could become pregnant need effective contraception. When methotrexate does not work or is not tolerated, mycophenolate mofetil (CellCept) or abatacept (Orencia), another immune-modifying medicine, may be used. Mycophenolate also must not be used during pregnancy, because it can cause pregnancy loss and birth defects, and it likewise requires effective contraception. Once a patch is no longer active, physical therapy can improve movement around stiff joints, though it is usually not pushed while the disease is still active. Reconstructive options, such as fat grafting or fillers, can improve dents in the face or limbs.
Morphea usually has an active phase, when patches are inflamed and may spread, followed by a quieter phase. Limited plaque morphea often settles by itself: about half of people see it regress within two and a half years. Linear, deep and generalized forms tend to stay active longer, often around five years, and some people go through flares and quiet periods for many years. With treatment, most people see activity settle within 3 to 12 months. The hardness softens more slowly, often over 2 to 5 years, and changes in skin color or loss of fat and muscle beneath the skin may remain. Morphea that starts in childhood is more likely to return after treatment ends, so follow-up continues for years, including after medication stops. The practical impact depends on location. A plaque on the trunk may be a cosmetic concern and occasionally itchy. A band across a joint can limit movement, and in a growing child it can lead to a shorter or thinner arm or leg. Facial forms can change facial symmetry and cause patchy hair loss on the scalp, which many people find emotionally hard; dermatology, rheumatology and, when needed, eye, dental and psychological care often work together. For children, regular checks of growth, joints and eyes are part of routine care.
See a dermatologist or primary care clinician about a patch of skin that is becoming firm, shiny or discolored, especially if it is growing, forms a band or appears on the face or scalp. If you already have morphea, contact your care team when a patch spreads, new ones appear or a purplish edge returns, since these can be signs of renewed activity. Also report stiffness or reduced movement in a nearby joint, or a difference in the size or length of a child's arms or legs. For facial or scalp morphea, contact the care team promptly about new or worsening headaches, changes in behavior or learning, or eye redness, pain or blurred vision. Seizures are the most common sign that this form has affected the brain: call 911 for a first seizure, a seizure lasting more than 5 minutes, or seizures that follow one another without the person waking in between, and report any seizure to the care team. If you take methotrexate or mycophenolate and become pregnant or are planning a pregnancy, contact your prescriber right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Localized Scleroderma is like, what's helped you, or ask the community a question.